You are here
Products
Ultra-Sensitive cfDNA BRAF mutation detection kit
Application notes: | 95°C, 10mins94°C, 1mins–>65°C, 3mins–>57°C, 1mins–>72°C, 1mins (x45 cycles)72°C, 10mins°10°C |
Conjugation Type: | Unconjugated |
Storage: | Stable for up to one year when store at -20°C. Avoid freeze/thaw cycles |
Alternative names: | BRAF, v-raf murine sarcoma viral oncogene homolog B1, serine/threonine-protein kinase B-raf, BRAF1 p94 94 kDa, B-raf protein, proto-oncogene B-Raf, murine sarcoma viral (v-raf) oncogene homolog B1, B-Raf proto-oncogene, serine/threo |
UNSPSC code: | 41106300 |
Ultra-Sensitive cfDNA BRAF mutation detection kit (Shipping Cost: €200.00)
Ultra-Sensitive cfDNA BRAF mutation detection kit
"#303030">BRAF, a kinase-encoding gene from the RAS/RAF/MEK/ERK pathway, recently has being studied in all malignant melanomas, including thyroid cancer, malignant melanoma, ovarian cancer, colorectal cancer. The most common mutations in BRAF occur at the valine at residue 600 (V600) within exon 15, and may be a predictive biomarker for limited response to anti-EGFR therapy.|Medaysis Ultra-Sensitive BRAF Mutation Detection Kit is a highly specific and sensitive PCR technique that is able to detect common somatic mutations in the BRAF gene (V600). Used with Sanger sequencing, it can detect less than 1% (as little as 20 ng to 100 ng of) mutant genes mixed with the wild-type. It is designed to amplify BRAF gene from formalin-fixed paraffin-embedded (FFPE) tissues, fresh or frozen tissues, cell smears, fine needle biopsies (FNA) or pleural effusion specimens.|Features of Medaysis mutation detection kit:1. Detect known and unknown mutation in target Exons2. Highly specific and sensitive mutation enrich technology3. Open system and easy to be done4. Minimal sample size - 5. No microdissection required.
Alternative names: BRAF, v-raf murine sarcoma viral oncogene homolog B1, serine/threonine-protein kinase B-raf, BRAF1 p94 94 kDa, B-raf protein, proto-oncogene B-Raf, murine sarcoma viral (v-raf) oncogene homolog B1, B-Raf proto-oncogene, serine/threo